Company Filing History:
Years Active: 2009
Title: Éva Ágainé Csongor: Innovator in Pharmacological Research
Introduction
Éva Ágainé Csongor is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmacology, particularly in the development of new therapeutic agents. His work focuses on addressing various mental health disorders and substance abuse issues.
Latest Patents
Éva Ágainé Csongor holds a patent for "Sulfonamide derivatives as D3-receptor ligands." This invention relates to new dopamine receptor subtype selective ligands, which are crucial for creating pharmacological compositions. These compositions are intended for the therapy and prevention of psychoses, including schizophrenia and schizo-affective disorders. The patent also addresses drug abuse, cognitive impairments, and various psychological and neurological disorders.
Career Highlights
He is currently associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. His work at the company has allowed him to explore innovative solutions in drug development and therapeutic applications. With a focus on improving mental health treatments, Csongor's contributions are vital in the ongoing battle against psychological disorders.
Collaborations
Éva Ágainé Csongor has collaborated with esteemed colleagues such as János Galambos and Katalin Nógrádi. These partnerships have fostered a collaborative environment that enhances research and development efforts in pharmacology.
Conclusion
Éva Ágainé Csongor is a distinguished inventor whose work in pharmacological research has the potential to transform treatment options for various mental health conditions. His innovative approach and dedication to improving therapeutic outcomes make him a valuable asset in the field.